arrow
Back
E

Elizabeth Fabre

Paris Cancer Institute

28H-index
166Paper Count
3.3KCitation Count
Published Papers 47
Publication Date
Resting energy expenditure as a predictor of immune checkpoint inhibitors response in older patients with non-small cell metastatic lung cancer: A pooled analysis of two prospective cohort studies
err2026-03-23
err0
PREAI
errMarie Pautas; Pascaline Boudou-Rouquette; Anne Jouinot; Anne Chahwakilian; Jennifer Arrondeau; Elizabeth Fabre; Sixtine de Percin; Olivier Huillard; Guillaume Ulmann; Diane Damotte; Audrey Mansuet-Lupo; Marie Wislez; Jérôme Alexandre; Florence Canouï-Poitrine; Elena Paillaud; François Goldwasser
errShare
errSave
Differential predictive value of resident memory CD8+T cell subpopulations in patients with non-small-cell lung cancer treated by immunotherapy
err2024-12-03
err0
errOAAI
errPaolini, Lea; Tran, Thi; Corgnac, Stephanie; Villemin, Jean-Philippe; Wislez, Marie; Arrondeau, Jennifer; Johannes, Ludger; Ulmer, Jonathan; Vieillard, Louis-Victorien; Pineau, Josephine; Gey, Alain; Quiniou, Valentin; Barennes, Pierre; Pham, Hang Phuong; Gruel, Nadege; Hasan, Milena; Libri, Valentina; Mella, Sebastien; De Percin, Sixtine; Boudou-Rouquette, Pascaline; Caidi, Aziza; Cremer, Isabelle; Blons, Helene; Leroy, Karen; Laurent-Puig, Pierre; De Saint Basile, Hortense; Gibault, Laure; Ravel, Patrice; Mami-Chouaib, Fathia; Goldwasser, Francois; Fabre, Elizabeth; Damotte, Diane; Tartour, Eric
errShare
errSave
Adverse Myocardial and vascular side effects of Immune Checkpoint Inhibitors: a prospective multimodal cardiovascular assessment (AMICI study)
err2024-10-28
err0
PREAI
errMirabel, M.; Eslami, A.; Thibault, C.; Oudard, S.; Mousseaux, E.; Wahbi, K.; Fabre, E.; Marijon, E.; Villefaillot, A.; Lillo-Lelouet, A.; Bruno, R. M.; Soulat, G.; Hulot, J. S.
errShare
errSave
Efficacy of first-line immune checkpoint inhibitors in pulmonary sarcomatoid carcinoma
err2024-09-01
err0
errOAAI
errBirsen, Gary; Gounant, Valerie; Girard, Nicolas; Cadranel, Jacques; Monnet, Isabelle; Raynaud-Donzel, Christine; Fabre, Elizabeth; Leprieur, Etienne Giroux; Leroy, Karen; Damotte, Diane; Alifano, Marco; Arrondeau, Jennifer; Creme, Isabelle; Chapron, Jeanne; Wislez, Marie
errShare
errSave
PrP© controls epithelial-to-mesenchymal transition in EGFR-mutated NSCLC: implications for TKI resistance and patient follow-up
err2024-08-15
err0
errOAAI
errLailler, Claire; Didelot, Audrey; Garinet, Simon; Berthou, Hugo; Sroussi, Marine; de Reynies, Aurelien; Dedhar, Shoukat; Martin-Lanneree, Severine; Fabre, Elizabeth; Le Pimpec-Barthes, Francoise; Perrier, Alexandre; Poindessous, Virginie; Mansuet-Lupo, Audrey; Djouadi, Fatima; Launay, Jean-Marie; Laurent-Puig, Pierre; Blons, Helene; Mouillet-Richard, Sophie
errShare
errSave
Successive next-generation sequencing strategy for optimal fusion gene detection in non-small-cell lung cancer in clinical practice
err2024-08-01
err2
PREAI
errGarinet, Simon; Lupo, Audrey; Denize, Thomas; Loyaux, Romain; Timsit, Sarah; Gazeau, Benoit; Fabre, Elizabeth; Maaradji, Zineb; Gibault, Laure; Giroux-leprieur, Etienne; Duchemann, Boris; Monnet, Isabelle; Jouveshomme, Stephane; Aldea, Mihaela; Besse, Benjamin; Le Pimpec-barthes, Francoise; Leroy, Karen; Wislez, Marie; Blons, Helene
errShare
errSave
Adverse myocardial and vascular side effects of immune checkpoint inhibitors: a prospective multimodal cardiovascular assessment
err2024-05-28
err5
PREAI
errMirabel, Mariana; Eslami, Assie; Thibault, Constance; Oudard, Stephane; Mousseaux, Elie; Wahbi, Karim; Fabre, Elizabeth; Terrier, Benjamin; Marijon, Eloi; Villefaillot, Aurelie; Fayol, Antoine; Dragon-Durey, Marie-Agnes; Le Louet, Agnes Lillo; Bruno, Rosa Maria; Soulat, Gilles; Hulot, Jean Sebastien
errShare
errSave
A novel Chr1-miR-200 driven whole transcriptome signature shapes tumor immune microenvironment and predicts relapse in early-stage lung adenocarcinoma
err2023-05-15
err1
errOAAI
errGarinet, Simon; Didelot, Audrey; Marisa, Laetitia; Beinse, Guillaume; Sroussi, Marine; Le Pimpec-Barthes, Francoise; Fabre, Elizabeth; Gibault, Laure; Laurent-Puig, Pierre; Mouillet-Richard, Sophie; Legras, Antoine; Blons, Helene
errShare
errSave
Preexisting autoantibodies as predictor of immune related adverse events (irAEs) for advanced solid tumors treated with immune checkpoint inhibitors (ICIs)
err2023-05-11
err13
errOAAI
errDaban, A.; Gonnin, C.; Phan, L.; Saldmann, A.; Granier, C.; Lillo-Lelouet, A.; Le Beller, C.; Pouchot, J.; Weiss, L.; Tartour, E.; Fabre, E.; Medioni, J.; Oudard, S.; Vano, Y. A.; Dragon-Durey, M. A.; Simonaggio, A.
errShare
errSave
CXCR6 expressing T cells: Functions and role in the control of tumors
err2022-10-12
err40
errOAAI
errMabrouk, Nesrine; Tran, Thi; Sam, Ikuan; Pourmir, Ivan; Gruel, Nadege; Granier, Clemence; Pineau, Josephine; Gey, Alain; Kobold, Sebastian; Fabre, Elizabeth; Tartour, Eric
errShare
errSave
Exposure-Response Analysis of Osimertinib in Patients with Advanced Non-Small-Cell Lung Cancer
err2022-09-01
err17
errOAAI
errRodier, Thomas; Puszkiel, Alicja; Cardoso, Evelina; Balakirouchenane, David; Narjoz, Celine; Arrondeau, Jennifer; Fallet, Vincent; Khoudour, Nihel; Guidi, Monia; Vidal, Michel; Decleves, Xavier; Csajka, Chantal; Alexandre, Jerome; Cadranel, Jacques; Fabre, Elizabeth; Wislez, Marie; Goldwasser, Francois; Blanchet, Benoit
errShare
errSave
Prognostic value of CD4+T lymphopenia in non-small cell lung Cancer
err2022-05-11
err22
errOAAI
errEberst, Guillaume; Vernerey, Dewi; Laheurte, Caroline; Meurisse, Aurelia; Kaulek, Vincent; Cuche, Laurie; Jacoulet, Pascale; Almotlak, Hamadi; Lahourcade, Jean; Gainet-Brun, Marie; Fabre, Elizabeth; Le Pimpec-Barthes, Francoise; Adotevi, Olivier; Westeel, Virginie
errShare
errSave
Development and validation of a host-dependent, PDL1-independent, biomarker to predict 6-month progression-free survival in metastatic non-small cell lung cancer (mNSCLC) patients treated with anti-PD1 immune checkpoint inhibitors (ICI) in the CERTIM Cohort: The ELY study
err2021-11-01
err10
errOAAI
errBoudou-Rouquette, Pascaline; Arrondeau, Jennifer; Gervais, Claire; Durand, Jean-Philippe; Fabre, Elizabeth; De Percin, Sixtine; Villeminey, Clementine Vaquin; Piketty, Anne-Catherine; Rassy, Nathalie; Ulmann, Guillaume; Damotte, Diane; Mansuet-Lupo, Audrey; Giraud, Frederique; Alifano, Marco; Wislez, Marie; Alexandre, Jerome; Jouinot, Anne; Goldwasser, Francois
errShare
errSave
CXCR6 deficiency impairs cancer vaccine efficacy and CD8+ resident memory T-cell recruitment in head and neck and lung tumors
err2021-03-10
err53
errOAAI
errKaraki, Soumaya; Blanc, Charlotte; Tran, Thi; Galy-Fauroux, Isabelle; Mougel, Alice; Dransart, Estelle; Anson, Marie; Tanchot, Corinne; Paolini, Lea; Gruel, Nadege; Gibault, Laure; Lepimpec-Barhes, Francoise; Fabre, Elizabeth; Benhamouda, Nadine; Badoual, Cecile; Damotte, Diane; Donnadieu, Emmanuel; Kobold, Sebastian; Mami-Chouaib, Fathia; Golub, Rachel; Johannes, Ludger; Tartour, Eric
errShare
errSave
Development and validation of a host-dependent, PDL1-independent, biomarker to predict 6-month progression-free survival in metastatic non-small cell lung cancer (mNSCLC) patients treated with anti-PD1 immune checkpoint inhibitors (ICI) in the CERTIM cohort: The ELY study
err2020-09-01
err0
errOAAI
errRouquette, P. Boudou; Arrondeau, J.; Gervais, C.; Jouinot, A.; Fabre, E.; De Percin, S.; Piketty, A-C.; Villeminey, C. Vaquin; Al-Rassy, N.; Ulmann, G.; Damotte, D.; Lupo-Mansuet, A.; Leroy, K.; Giraud, F.; Alexandre, J.; Alifano, M.; Cynober, L.; Wislez, M.; Durand, J-P.; Goldwasser, F.
errShare
errSave
Should I stay or should I go: Optimal duration for antiPD(L)1 therapy
err2020-09-01
err0
errOAAI
errChen, J.; Arrondeau, J.; Jouinot, A.; Rouquette, P. Boudou; Fabre, E.; Giraud, F.; Chapron, J.; Huillard, O.; Lupo-Mansuet, A.; Damotte, D.; Alexandre, J.; Wislez, M.; Goldwasser, F.
errShare
errSave
Population Pharmacokinetics of Erlotinib in Patients With Non-small Cell Lung Cancer: Its Application for Individualized Dosing Regimens in Older Patients
err2020-07-01
err14
PREAI
errCardoso, Evelina; Guidi, Monia; Khoudour, Nihel; Boudou-Rouquette, Pascaline; Fabre, Elizabeth; Tlemsani, Camille; Arrondeau, Jennifer; Goldwasser, Francois; Vidal, Michel; Schneider, Marie Paule; Wagner, Anna Dorothea; Widmer, Nicolas; Blanchet, Benoit; Csajka, Chantal
errShare
errSave
Distinct prognostic value of circulating anti-telomerase CD4+ Th1 immunity and exhausted PD-1+/TIM-3+ T cells in lung
err2019-07-30
err66
errOAAI
errLaheurte, Caroline; Dosset, Magalie; Vernerey, Dewi; Boullerot, Laura; Gaugler, Beatrice; Gravelin, Eleonore; Kaulek, Vincent; Jacquin, Marion; Cuche, Laurie; Eberst, Guillaume; Jacoulet, Pascale; Fabre, Elizabeth; Le Pimpec-Barthes, Francoise; Tartour, Eric; Bittencourt, Marcelo De Carvalho; Westeel, Virginie; Adotevi, Olivier
errShare
errSave
Predictive value of soluble PD-1, PD-L1, VEGFA, CD40 ligand and CD44 for nivolumab efficacy in advanced non-small cell lung cancer
err2019-07-01
err0
PREAI
errMeyo, Manuela Tiako; Jouinot, Anne; Giroux-Leprieur, Etienne; Fabre, Elizabeth; Boudou-Rouquette, Pascaline; Bellesoeur, Audrey; Arrondeau, Jennifer; Blons, Helene; Mansuet-Lupo, Audrey; Damotte, Diane; Vidal, Michel; Goldwasser, Francois; Alexandre, Jerome; Blanchet, Benoit
errShare
errSave
Circulating NKp46+ Natural Killer cells have a potential regulatory property and predict distinct survival in Non-Small Cell Lung Cancer
err2018-10-19
err27
errOAAI
errPicard, Emilie; Godet, Yann; Laheurte, Caroline; Dosset, Magalie; Galaine, Jeanne; Beziaud, Laurent; Loyon, Romain; Boullerot, Laura; Joseph, Elodie Lauret Marie; Spehner, Laurie; Jacquin, Marion; Eberst, Guillaume; Gaugler, Beatrice; Le Pimpec-Barthes, Francoise; Fabre, Elizabeth; Westeel, Virginie; Caignard, Anne; Borg, Christophe; Adotevi, Olivier
errShare
errSave